Literature DB >> 10051023

Homozygosity in Huntington's disease.

A Dürr, V Hahn-Barma, A Brice, C Pêcheux, C Dodé, J Feingold.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10051023      PMCID： PMC1734296     

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  10 in total

Review 1.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

2.  A molecular investigation of true dominance in Huntington's disease.

Authors:  Y Narain; A Wyttenbach; J Rankin; R A Furlong; D C Rubinsztein
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

Review 3.  Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.

Authors:  Sarah J Tabrizi; Carlos Estevez-Fraga; Willeke M C van Roon-Mom; Michael D Flower; Rachael I Scahill; Edward J Wild; Ignacio Muñoz-Sanjuan; Cristina Sampaio; Anne E Rosser; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2022-07       Impact factor: 59.935

Review 4.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

5.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Authors:  J-M Lee; E M Ramos; J-H Lee; T Gillis; J S Mysore; M R Hayden; S C Warby; P Morrison; M Nance; C A Ross; R L Margolis; F Squitieri; S Orobello; S Di Donato; E Gomez-Tortosa; C Ayuso; O Suchowersky; R J A Trent; E McCusker; A Novelletto; M Frontali; R Jones; T Ashizawa; S Frank; M H Saint-Hilaire; S M Hersch; H D Rosas; D Lucente; M B Harrison; A Zanko; R K Abramson; K Marder; J Sequeiros; J S Paulsen; G B Landwehrmeyer; R H Myers; M E MacDonald; J F Gusella
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

6.  Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.

Authors:  Belvin Gong; Catherine Kielar; A Jennifer Morton
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

7.  Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.

Authors:  Jeremy M Van Raamsdonk; Jacqueline Pearson; Zoe Murphy; Michael R Hayden; Blair R Leavitt
Journal:  BMC Neurosci       Date:  2006-12-05       Impact factor: 3.288

Review 8.  Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.

Authors:  Rita Guerreiro; José Brás; John Hardy; Andrew Singleton
Journal:  Hum Mol Genet       Date:  2014-05-02       Impact factor: 6.150

9.  A novel and accurate full-length HTT mouse model for Huntington's disease.

Authors:  Sushila A Shenoy; Sushuang Zheng; Wencheng Liu; Yuanyi Dai; Yuanxiu Liu; Zhipeng Hou; Susumu Mori; Yi Tang; Jerry Cheng; Wenzhen Duan; Chenjian Li
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.140

Review 10.  Huntington's disease: nearly four decades of human molecular genetics.

Authors:  James F Gusella; Jong-Min Lee; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.